angelmicin b has been researched along with Cell Transformation, Neoplastic in 1 studies
*Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukazawa, H; Furumai, T; Hanada, M; Li, PM; Mizuno, S; Nihei, Y; Nishio, M; Oki, T; Uehara, Y; Yamamoto, C | 1 |
1 other study(ies) available for angelmicin b and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Angelmicins, new inhibitors of oncogenic src signal transduction.
Topics: 3T3 Cells; Animals; Anthraquinones; Antibiotics, Antineoplastic; Cell Transformation, Neoplastic; Genes, src; Mice; Protein-Tyrosine Kinases; Signal Transduction | 1993 |